Clinical Trials on Refractory Neuroblastoma
Total 3264 results
-
Y-mAbs TherapeuticsWithdrawnNeuroblastomaKorea, Republic of, Singapore, Hong Kong, Russian Federation
-
Nova Laboratories LimitedCompleted
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Miguel PampaloniMolecular Insight Pharmaceuticals, Inc.; Jubilant DraxImage Inc.Terminated
-
Baylor College of MedicineCompleted
-
Memorial Sloan Kettering Cancer CenterCompleted
-
New Approaches to Neuroblastoma Therapy ConsortiumCompletedNeuroblastomaCanada, United States
-
Samsung Medical CenterCompletedNeuroblastomaKorea, Republic of
-
New Approaches to Neuroblastoma Therapy ConsortiumUniversity of Southern California; SignalRX Pharmaceuticals, Inc.Terminated
-
Children's Mercy Hospital Kansas CityUniversity of KansasCompletedNeuroblastomaUnited States
-
St. Jude Children's Research HospitalTerminatedNeuroblastomaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedNeuroblastomaUnited States, Canada, Puerto Rico, Australia, Netherlands, Switzerland, New Zealand
-
University of CologneCompleted
-
Children's Oncology GroupNational Cancer Institute (NCI)Completed
-
Xinhua Hospital, Shanghai Jiao Tong University...Unknown
-
Children's Oncology GroupNational Cancer Institute (NCI)Completed
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedNeuroblastoma
-
United TherapeuticsCompleted
-
University of Alabama at BirminghamTerminatedNeuroblastomaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedNeuroblastomaUnited States, Australia
-
Children's Hospital Medical Center, CincinnatiCompleted
-
Emory UniversityChildren's Healthcare of AtlantaWithdrawn
-
European Infant Neuroblastoma Study Group - 1999CompletedNeuroblastomaSwitzerland, Denmark, Spain, Belgium, France, Austria, Italy, Norway, Portugal, Sweden, United Kingdom
-
Children's Cancer and Leukaemia GroupUnknownNeuroblastomaUnited Kingdom, Ireland
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedNeuroblastomaUnited States, Canada
-
National Taiwan University HospitalCompleted
-
National Taiwan University HospitalNational Science Council, Taiwan; National Taiwan UniversityUnknown
-
M.D. Anderson Cancer CenterAstraZenecaTerminatedNeuroblastomaUnited States
-
University Hospital, Clermont-FerrandUnknown
-
GE HealthcareApproved for marketingNeuroblastomaUnited States
-
St. Jude Children's Research HospitalNational Institutes of Health (NIH)Completed
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple Myeloma | Hematopoietic and Lymphatic System NeoplasmUnited States
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple Myeloma | Hematopoietic and Lymphatic System NeoplasmUnited States
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple Myeloma
-
M.D. Anderson Cancer CenterCompletedEvaluation of the Anti-CD-33 Immunotoxin Hum-195/rGel in Patients With Advanced Myeloid MalignanciesAcute Myeloid Leukemia | Myeloproliferative Disorders | Chronic Myelomonocytic Leukemia | Anemia, Refractory, With Excess of BlastsUnited States
-
Shenzhen Core Medical Technology CO.,LTD.Not yet recruiting
-
Imperial College LondonMedical Research Council; Imperial College Healthcare Nissen FundRecruitingRefractory AnginaUnited Kingdom
-
Justin Parker Neurological InstituteCompletedChronic Refractory Low Back and Leg PainUnited States
-
All India Institute of Medical Sciences, New DelhiCouncil of Scientific and Industrial Research, IndiaCompleted
-
National University Hospital, SingaporeUnknownAdvanced Glaucoma | Refractory GlaucomaSingapore
-
Massachusetts General HospitalNational Cancer Institute (NCI)RecruitingNeuroblastoma | GanglioneuroblastomaUnited States
-
Children's Mercy Hospital Kansas CityCenter for Cell and Gene Therapy, Baylor College of MedicineCompleted
-
M.D. Anderson Cancer CenterRecruitingRefractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Richter Syndrome | Refractory Mantle Cell Lymphoma | Refractory Aggressive B-Cell Non-Hodgkin Lymphoma | Refractory High Grade B-Cell Lymphoma | Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma | Refractory... and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid NeoplasmUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLC; Seagen Inc.WithdrawnBrentuximab Vedotin and Pembrolizumab in Treating Patients With Recurrent Peripheral T-Cell LymphomaRecurrent Angioimmunoblastic T-Cell Lymphoma | Refractory Angioimmunoblastic T-Cell Lymphoma | Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified | Recurrent Enteropathy-Associated T-Cell Lymphoma | Recurrent Follicular T-Cell Lymphoma | Recurrent Hepatosplenic T-Cell Lymphoma | Recurrent... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRefractory Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Recurrent Cutaneous Melanoma | Recurrent Malignant Female Reproductive System Neoplasm | Refractory Malignant Female Reproductive System Neoplasm | Recurrent Lip and Oral Cavity Carcinoma | Recurrent Malignant Endocrine... and other conditionsUnited States
-
Sun Yat-sen UniversityChipscreen Biosciences, Ltd.Not yet recruitingRelapsed or Refractory DLBCL
-
HutchmedCompletedRelapsed or Refractory LymphomaUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingRefractory Leukemia | Recurrent LeukemiaUnited States